Investing in companies that are forced to write down their assets due to botched acquisitions can have devastating consequences for investors.
News & Analysis: Bausch Health Companies
BHC earnings call for the period ending March 31, 2020.
How one company's enormous debt stack is preventing a fresh start.
Why Align Technology, Bausch Health, Momenta Pharmaceuticals, and ShockWave Medical Stocks Soared Today
Optimism that the worst might be over with the COVID-19 outbreak fueled investors' enthusiasm for these healthcare stocks.
Despite its high debt levels, Bausch Health is well positioned to survive an economic downturn because of its healthy cash flow.
The stock rebounded on Friday in lockstep with the broader biopharmaceutical industry.
Bausch's shares are being pulled under by the marketwide sell-off today.
Hint: It's what caused nearly every stock to sink.
These three pharma stocks offer safe harbor in a volatile market.
BHC earnings call for the period ending December 31, 2019.